参芪降糖胶囊联合盐酸二甲双胍治疗气阴两虚证2型糖尿病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.1

基金项目:


Clinical Study on Shenqi Jiangtang Capsules Combined with Metformin Hydrochloride for Type 2 Diabetes Mellitus with Deficiency of Both Qi and Yin Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察参芪降糖胶囊联合盐酸二甲双胍治疗气阴两虚证 2 型糖尿病的临床疗效。方法:选取2 型糖尿病患者 182 例,按照随机数字表法分为对照组和观察组各 91 例。对照组予盐酸二甲双胍治疗;观察组在对照组的基础上予参芪降糖胶囊治疗。2 组疗程均为 12 周。比较 2 组临床疗效及治疗前后血糖指标 [ 空腹血糖(FBG)、餐后 2 h 血糖(P2hBG)、糖化血红蛋白(HbA1c)]、气阴两虚证侯评分以及胰岛 β 细胞功能指标 [ 空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、胰岛 β 细胞功能指数(HOMA-β) ] 变化。结果:观察组总有效率为 95.60%,对照组为 85.71%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组 FBG、P2hBG、HbA1c 均较治疗前降低(P<0.05);且观察组上述指标均低于对照组(P<0.05)。治疗后,2 组气阴两虚证证候评分均较治疗前降低(P<0.05),且观察组气阴两虚证证候评分低于对照组(P<0.05)。治疗后,2 组 FINS、HOMA-IR 水平均较治疗前降低(P<0.05),HOMA-β 水平均较治疗前升高(P<0.05);且观察组上述各项指标改善较对照组更显著(P<0.05)。结论:参芪降糖胶囊联合盐酸二甲双胍治疗气阴两虚证 2 型糖尿病的疗效显著,能有效控制血糖,改善胰岛 β 细胞功能和中医证候。

    Abstract:

    Abstract: Objective: To observe the curative effect of Shenqi Jiangtang capsules combined with metformin hydrochloride for type 2 diabetes mellitus with deficiency of both qi and yin syndrome. Methods: A total of 182 cases of patients with type 2 diabetes mellitus were selected and divided into the control group and the observation group according to the random number table method,with 91 cases in each group. The control group was treated with metformin hydrochloride, and the observation group was additionally treated with Shenqi Jiangtang capsules based on the treatment of the control group. Both groups were treated for 12 weeks. The changes in the blood glucose indexes including fasting blood glucose (FBG),postprandial 2 h blood glucose(P2hBG) and hemoglobin A1c(HbA1c),the scores of deficiency of both qi and yin syndrome,and the pancreatic β cell function including fasting insulin(FINS),homeostasis model assessment of insulin resistance index(HOMA- IR) and homeostasis model assessment of β cell function(HOMA-β) before and after treatment and the clinical effects in the two groups were compared. Results:The total effective rate was 95.60% in the observation group and 85.71% in the control group, the difference being significant(P<0.05). After treatment,the FBG,P2hBG and HbA1c in the two groups were decreased when compared with those before treatment(P<0.05); the above indexes in the observation group were significantly lower than those in the control group(P<0.05). After treatment,the scores of deficiency of both qi and yin syndrome in the two groups were decreased when compared with those before treatment(P<0.05),and the score of deficiency of both qi and yin syndrome was significantly lower than that in the control group(P<0.05). After treatment,the levels of FINS and HOMA-IR in the two groups were decreased when compared with those before treatment(P<0.05),and the HOMA-β levels were increased(P<0.05); the improvement of the above indexes in the observation group was more significant than that in the control group(P<0.05). Conclusion:Shenqi Jiangtang capsules combined with metformin hydrochloride has an obvious curative effect in treating type 2 diabetes mellitus with deficiency of both qi and yin syndrome,which can effectively control blood glucose and improve the Chinese medicine syndrome and pancreatic β cell function.

    参考文献
    相似文献
    引证文献
引用本文

余佩芳,汪洋鹏.参芪降糖胶囊联合盐酸二甲双胍治疗气阴两虚证2型糖尿病临床研究[J].新中医,2022,54(14):91-94

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-07-21
  • 出版日期:
文章二维码